In early February 2026, Omnicell reported fourth-quarter 2025 revenue of US$313.98 million with a small net loss of US$2.03 million, and issued first-quarter 2026 revenue guidance of US$300 million to ...
Omnicell’s fourth quarter was met with a significant negative market reaction, as the company delivered revenue in line with Wall Street expectations but posted a notable shortfall in non-GAAP ...
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results